Financhill
Back

Goldman Sachs Access Treasury 0-1 Year ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Sell
6

GBIL
Goldman Sachs Access Treasury 0-1 Year ETF

Last Price:
$99.94
Seasonality Move:
0.01%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Sell
6
Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) is a Sell

Is Goldman Sachs Access Treasury 0-1 Year ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Access Treasury 0-1 Year ETF [GBIL] share price is $99.94. The Score for GBIL is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • GBIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GBIL Stock Price Chart

What is Goldman Sachs Access Treasury 0-1 Year ETF's stock price today?

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

GBIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 34.08 Sell
Chaikin Money Flow: 600701 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100 - 100.2) Sell
Bollinger Bands (100): (99.98 - 100.16) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

GBIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.17 Sell
20-day SMA: 100.09 Sell
50-day SMA: 100.08 Sell
200-day SMA: 100.04 Sell
8-day EMA: 100.14 Sell
20-day EMA: 100.12 Sell
50-day EMA: 98.71 Buy
200-day EMA: 65.75 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

Goldman Sachs Access Treasury 0-1 Year ETF Earnings Growth & GBIL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

Goldman Sachs Access Treasury 0-1 Year ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):